Trial · NCT01794741
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | epistaxis | Respiratory, thoracic and mediastinal disorders | Dymista Nasal Spray | 30 | 304 | |
| other | epistaxis | Respiratory, thoracic and mediastinal disorders | Fluticasone Propionate Nasal Spray | 9 | 101 | |
| other | headache | General disorders | Dymista Nasal Spray | 20 | 304 | |
| other | headache | General disorders | Fluticasone Propionate Nasal Spray | 3 | 101 | |
| other | cough | Respiratory, thoracic and mediastinal disorders | Dymista Nasal Spray | 11 | 304 | |
| other | cough | Respiratory, thoracic and mediastinal disorders | Fluticasone Propionate Nasal Spray | 3 | 101 | |
| other | pyrexia | General disorders | Dymista Nasal Spray | 10 | 304 | |
| other | pyrexia | General disorders | Fluticasone Propionate Nasal Spray | 2 | 101 | |
| other | oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Dymista Nasal Spray | 9 | 304 | |
| other | oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Fluticasone Propionate Nasal Spray | 0 | 101 | |
| other | otitis media | Ear and labyrinth disorders | Dymista Nasal Spray | 9 | 304 | |
| other | otitis media | Ear and labyrinth disorders | Fluticasone Propionate Nasal Spray | 3 | 101 | |
| other | vomiting | Gastrointestinal disorders | Dymista Nasal Spray | 9 | 304 | |
| other | vomiting | Gastrointestinal disorders | Fluticasone Propionate Nasal Spray | 2 | 101 | |
| other | abdominal pain upper | Gastrointestinal disorders | Dymista Nasal Spray | 8 | 304 | |
| other | abdominal pain upper | Gastrointestinal disorders | Fluticasone Propionate Nasal Spray | 2 | 101 | |
| other | upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | Dymista Nasal Spray | 8 | 304 | |
| other | upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | Fluticasone Propionate Nasal Spray | 1 | 101 | |
| serious | gastroenteritis elevated LFT | Gastrointestinal disorders | Dymista Nasal Spray | 1 | 304 | 1 |
| serious | gastroenteritis elevated LFT | Gastrointestinal disorders | Fluticasone Propionate Nasal Spray | 0 | 101 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01794741/events